Segment Information - Summary of Selected Financial Information with Respect to Single Operating Segment (Detail) - USD ($) |
8 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Apr. 30, 2025 |
Apr. 30, 2024 |
|
| Segment expenses and other segment items | ||||
| Total revenues | $ 49,078,000 | |||
| Cost of revenue | 3,081,000 | |||
| Clinical development | 14,723,000 | $ 43,166,000 | $ 46,520,000 | |
| Research | 12,851,000 | 19,713,000 | 36,074,000 | |
| Regulatory & QA | 5,239,000 | 8,830,000 | 3,573,000 | |
| Commercial | 89,441,000 | 62,859,000 | 18,481,000 | |
| Other SG&A | 35,780,000 | 53,427,000 | 35,797,000 | |
| Other income | 1,480,000 | $ 6,576,000 | 7,943,000 | 13,801,000 |
| Income tax expense (benefit) | (1,033,000) | 3,392,000 | 0 | |
| Segment net loss | (109,524,000) | (183,444,000) | (126,644,000) | |
| Reconciliation of segment profit or loss: | ||||
| Adjustments and reconciling items | 0 | 0 | 0 | |
| Consolidated net loss | $ (109,524,000) | $ (110,454,000) | $ (183,444,000) | $ (126,644,000) |
| X | ||||||||||
- Definition Clinical development. No definition available.
|
| X | ||||||||||
- Definition Commercial expenses. No definition available.
|
| X | ||||||||||
- Definition Net Income Loss Before Adjustments No definition available.
|
| X | ||||||||||
- Definition Reconciliation Of Segment Profit Or Loss Adjustments No definition available.
|
| X | ||||||||||
- Definition Regulatory and QA expenses. No definition available.
|
| X | ||||||||||
- Definition Research expenses. No definition available.
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of selling, general and administrative expense classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|